General Information of Drug (ID: DMWMRLS)

Drug Name
UNC1215 Drug Info
Synonyms
UNC1215; 1415800-43-9; UNC-1215; UNC 1215; (2-(phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone); CHEMBL2426364; 2-Phenylamino-1,4-bis(4-(pyrrolidinyl)piperidinyl)benzamide; [2-(Phenylamino)benzene-1,4-Diyl]bis{[4-(Pyrrolidin-1-Yl)piperidin-1-Yl]methanone}; MLS006011024; GTPL8232; SCHEMBL19730381; CHEBI:95086; EX-A193; AOB4333; MolPort-028-720-812; HMS3652P22; KS-00000T6B; BCP07393; ZINC83253967; s7088; BDBM50440614; 2782AH; AKOS024458279; SB19337; CS-1646; NCGC00344623-12; NCGC00344623-02; SMR004702819
Cross-matching ID
PubChem CID
57339144
ChEBI ID
CHEMBL2426364
CAS Number
CAS 1415800-43-9
TTD Drug ID
D0W9RR

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.36 0.00e+0 34/36 (94.44%) PRIM1;RFC2;LIG1;...
Spliceosome 1.95 7.37e-3 101/150 (67.33%) PRPF4;PPIH;HSPA8;...
Homologous recombination 1.92 4.91e-3 35/41 (85.37%) BRCA1;BLM;RAD54B;...
RNA transport 1.88 3.68e-3 128/186 (68.82%) SUMO3;NUP37;EIF1AY;...
Mismatch repair 1.88 2.95e-3 22/23 (95.65%) RFC2;MSH2;LIG1;...
Nucleotide excision repair 1.86 3.68e-3 40/47 (85.11%) CETN2;RFC2;MNAT1;...
Ribosome 1.85 3.16e-3 113/158 (71.52%) RPS4Y1;RPS5;MRPL23;...
Base excision repair 1.84 2.76e-3 29/33 (87.88%) PARP2;LIG1;PCNA;...
Ubiquinone and other terpenoid-quinone biosynthesis 1.82 6.55e-3 9/11 (81.82%) NQO1;COQ3;HPD;...
Fanconi anemia pathway 1.80 8.84e-3 36/54 (66.67%) BRCA1;BLM;USP1;...
Oxidative phosphorylation 1.79 9.38e-3 93/133 (69.92%) COX7B;NDUFA4L2;CYC1;...
Amyotrophic lateral sclerosis 1.71 2.33e-2 267/364 (73.35%) GPX2;MAPK13;COX7B;...
RNA polymerase 1.68 2.83e-2 23/31 (74.19%) POLR2K;POLR3K;POLR2C;...
Parkinson disease 1.62 5.00e-2 176/249 (70.68%) COX7B;MAP3K5;TRAP1;...
Hematopoietic cell lineage -1.82 3.08e-2 90/99 (90.91%) IL11RA;IL4R;CD1D;...
ECM-receptor interaction -1.85 1.73e-2 80/88 (90.91%) ITGA10;COL4A4;THBS2;...
Allograft rejection -1.87 1.23e-2 32/38 (84.21%) IL5;IL12B;HLA-DMB;...
Graft-versus-host disease -1.92 8.22e-3 32/42 (76.19%) HLA-DMB;HLA-DPB1;HLA-DPA1;...
Thyroid cancer -1.93 1.23e-2 36/37 (97.3%) BAX;PAX8;GADD45B;...
Regulation of lipolysis in adipocytes -2.01 0.00e+0 52/55 (94.55%) PTGS1;ADCY9;LIPE;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow
Neuroblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SH-SY5Y CVCL_0019 Homo sapiens 0.04uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 10uM 6H, 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.04uM - 10uM 24H
Normal (Epithelial)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HME1 CVCL_2950 Homo sapiens 0.04uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.04uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.04uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.04uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 0.04uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.04uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.04uM - 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.04uM - 10uM 6H, 24H
A549/Asc-1 CVCL_YA87 Homo sapiens 0.04uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 0.04uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.04uM - 10uM 6H, 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.04uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.04uM - 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.04uM - 10uM 6H, 24H
SK-L CVCL_1699 Homo sapiens 0.04uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.04uM - 10uM 24H